Improving maternal and infant health outcomes
Synapse provides a series of tests ranging from prenatal, perinatal to postnatal care. We believe that a healthy baby starts from the womb and therefore bring to you the BabySafe brand on your journey to motherhood.
BabySafe FTS
BabySafe FTS
First Trimester Screening is a prenatal test for risk calculation of Trisomy 21 and Trisomy 18/13 using maternal serum biochemistry results (Free β-hCG and PAPP-A) combined with first trimester ultrasound parameters (CRL and NT)
Specimen Type: 1 x 8 mL Serum
LTAT (Hours) : 24 – 48
BabySafe Pre-eclampsia Screen
BabySafe Pre-eclampsia Screen
Pre-eclampsia (First Trimester) Screening is a prenatal test for risk calculation of pre-eclampsia (PE) using maternal serum biochemistry results (PAPP-A and PlGF) combined with first trimester ultrasound parameters (CRL and Uterine Artery Pulsatility Index). The risk of early onset is the risk of developing PE during early pregnancy, i.e. week 20, whereas the risk of late onset is the risk of developing PE during late pregnancy, i.e. week 34.
First Trimester Pre-Eclampsia Screen
Risk calculation of pre-eclampsia using maternal serum biochemistry (PAPP-A and PlGF) combined with ultrasound parameters
Specimen Type: Nasopharyngeal Swab
LTAT (Hours) : 12 – 24
Second Trimester Pre-Eclampsia Test
Prenatal test for the diagnosis of pre-eclampsia based on the sFlt¬1/PlGF ratio.
Specimen Type: 1 x 8 mL Serum
LTAT (Hours) :24 – 48
BabySafe Non-Invasive Prenatal Testing (NIPT)
Learn More
BabySafe Non-Invasive Prenatal Testing (NIPT)
Non-Invasive Prenatal Testing (NIPT) is a prenatal screening of fetal chromosomal abnormalities by sequencing the maternal plasma cell-free DNA (cfDNA) derived from the pregnancy.
It aims to evaluate possible chromosomal conditions in a pregnancy including 3 common trisomies (Trisomy 21, 18 and 13), 22 fetal chromosomal aneuploidies, 20 or 60 microdeletion/ microduplication syndromes.
Using Next Generation Sequencing Technology, NIPT is a highly sensitive and specific approach that offer genetic screening as early as 10-11 weeks into a pregnancy. It provides high detection rates, low false-positive results, and no risk to mother and baby.
For more information please click here:
BabySafe Inborn Errors of Metabolism (IEM)
Learn More
BabySafe Inborn Errors of Metabolism (IEM)
Inborn errors of metabolism are rare genetic (inherited) disorders in which the body cannot properly turn food into energy. The disorders are usually caused by defects in specific proteins (enzymes) that help break down (metabolize) parts of food.
For more information please click here:
Get intouch with us to find out more about the solutions we provide at Synapse
Quick Links
- About Us
- myPreciseDNA
- BabySafe Test
- MedicSkills
- Nexus Lab
Our Vision
To become the leading regional healthcare testing provider by offering unique screening and diagnostic solutions that better the nature of conventional healthcare services.